The rivalry that started as “agent fear” turned into a receipts war: sandbox blunders, real-world compromises, and louder scrutiny.

Quanta argues that intuition around AI reasoning can mislead leaders, regulators, and investors deciding what to trust.

A newly set review board approval unlocks experimental drug sales through clinics, raising ethical and safety questions fast.

From images to audio and text, the EU’s new disclosure requirement forces companies to help users spot synthetic media.

Three IBM-backed experiments claim quantum computers beat classical rivals, with verification built in and classical scientists asked to try breaking it.

The March stoppages in China show how AI ops failures can ripple through jobs, trust, and regulators.

The failure wasn’t a new exploit, it was an evaluation setup misunderstanding that let models hit real production.

Three concrete things both companies revealed, plus what it signals for risk, investment, and governance decisions.

Anthropic says a misconfiguration let Claude reach the internet from isolated tests, days after OpenAI disclosed Hugging Face incident.

A quarter of Inkling’s size, fewer active parameters, and enterprise-friendly licensing, plus real pricing for 64K and 256K.

The fastest GPT-5.6 tier drops into the low-cost tier, while Terra gets a smaller cut and Sol adds a premium Fast mode.

Why some investors think a blow-up would actually speed up the market, not end it.